Your request to link to rcsb for Trypsin
- 5AUI: crystal structure of ferredoxin (10.1021/ACS.BIOCHEM.5B00601 )
- 1C5O: structural basis for selectivity of a small molecule, s1-binding, sub- micromolar inhibitor of urokinase type plasminogen activator (10.1016/S1074-5521(00)00104-6 )
- 1C5Z: structural basis for selectivity of a small molecule, s1-binding, sub- micromolar inhibitor of urokinase type plasminogen activator (10.1016/S1074-5521(00)00104-6 )
- 1C5P: structural basis for selectivity of a small molecule, s1-binding, sub- micromolar inhibitor of urokinase type plasminogen activator (10.1016/S1074-5521(00)00104-6 )
- 5Z87: structural of a novel b-glucosidase emgh1 at 2.3 angstrom from erythrobacter marinus
- 5YX6: crystal structure of rv3272 from m. tuberculosis orthorhombic form (10.1016/J.BBAPAP.2018.10.011 )
- 3PCZ: endothiapepsin in complex with benzamidine (10.1002/CMDC.201100490 )
- 5NVJ: sh3 domain from mouse cortactin (c 1 2 1 crystal form)
- 3PVK: secreted aspartic protease 2 in complex with benzamidine (10.1002/CMDC.201100490 )
- 4OMR: crystal structure of tfu_1878, a putative enoyl-coa hydratase from thermobifida fusca yx in complex with acetoacetyl-coa
- 5MOQ: joint x-ray/neutron structure of cationic trypsin in complex with benzamidine (10.1038/S41467-018-05769-2 )
- 6JO2: ferredoxin i from thermosynechococcus elongatus (10.1016/J.BBABIO.2019.148084 )
- 1TIO: high packing density form of bovine beta-trypsin in cyclohexane (10.1016/S0167-4838(98)00226-X )
- 4J2S: macrolepiota procera ricin b-like lectin (mpl) in complex with di- lacnac
- 5MNH: cationic trypsin in complex with benzamidine (deuterated sample at 295 k) (10.1038/S41467-018-05769-2 )
- 5MNG: cationic trypsin in complex with benzamidine (deuterated sample at 100 k) (10.1038/S41467-018-05769-2 )
- 4IZX: macrolepiota procera ricin b-like lectin (mpl) in complex with lactose
- 6I44: allosteric activation of human prekallikrein by apple domain disc rotation (10.1111/JTH.14418 )
- 5MO0: neutron structure of cationic trypsin in complex with benzamidine (10.1038/S41467-018-05769-2 )
- 1ZVW: the crystal structure of trpd (rv2192c) from mycobacterium tuberculosis in complex with prpp and magnesium (10.1016/J.JMB.2005.11.016 )
- 6S32: crystal structure of ene-reductase ctoye from chroococcidiopsis thermalis. (10.1007/S00253-019-10287-2 )
- 1HJ8: 1.00 aa trypsin from atlantic salmon (10.1107/S0907444901000646 )
- 6Q39: complex of arginase 2 with example 49 (10.1021/ACS.JMEDCHEM.9B00931 )
- 6Q37: complex of arginase 2 with example 23 (10.1021/ACS.JMEDCHEM.9B00931 )
- 1XX4: crystal structure of rat mitochondrial 3,2-enoyl-coa (10.1110/PS.041303705 )
- 2PSM: crystal structure of interleukin 15 in complex with interleukin 15 receptor alpha (10.1074/JBC.M706150200 )
- 1F5K: urokinase plasminogen activator b-chain-benzamidine complex (10.1006/JMBI.2000.3966 )
- 4XN6: crystal structure at room temperature of hen-egg lysozyme in complex with benzamidine (10.1107/S1399004715010342 )
- 5JD4: crystal structure of lae6 ser161ala mutant, an alpha/beta hydrolase enzyme from the metagenome of lake arreo, spain
- 4P9H: crystal structure of 8anc195 fab in complex with gp120 of 93th057 hiv- 1 and soluble cd4 d1d2 (10.1016/J.CELREP.2014.04.001 )
- 5PB1: crystal structure of factor viia in complex with benzenecarboximidamide
- 2BY9: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
- 2BY8: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
- 2BY7: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
- 2BY6: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
- 2BY5: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
- 2BYA: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
- 1C1N: recruiting zinc to mediate potent, specific inhibition of serine proteases (10.1038/35422 )
- 2ANW: expression, crystallization and three-dimensional structure of the catalytic domain of human plasma kallikrein: implications for structure-based design of protease inhibitors (10.1074/JBC.M506766200 )
- 2ANY: expression, crystallization and the three-dimensional structure of the catalytic domain of human plasma kallikrein: implications for structure-based design of protease inhibitors (10.1074/JBC.M506766200 )